|
Volumn 359, Issue 9314, 2002, Pages 1349-1350
|
Guidelines for acute coronary syndrome without ST elevation [6] (multiple letters)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ABCIXIMAB;
ACETYLSALICYLIC ACID;
ANTILIPEMIC AGENT;
ANTITHROMBOCYTIC AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CLOPIDOGREL;
DALTEPARIN;
ENOXAPARIN;
FIBRINOGEN RECEPTOR ANTAGONIST;
HEPARIN;
TIROFIBAN;
IMMUNOGLOBULIN F(AB) FRAGMENT;
MONOCLONAL ANTIBODY;
DRUG DERIVATIVE;
FIBRINOGEN RECEPTOR;
TICLOPIDINE;
ANTICOAGULATION;
CLINICAL TRIAL;
DRUG EFFECT;
DRUG SAFETY;
HEART MUSCLE ISCHEMIA;
HUMAN;
LETTER;
MORTALITY;
PRIORITY JOURNAL;
ST SEGMENT ELEVATION;
CONTROLLED CLINICAL TRIAL;
CORONARY ARTERY DISEASE;
ELECTROCARDIOGRAPHY;
NOTE;
PRACTICE GUIDELINE;
RANDOMIZED CONTROLLED TRIAL;
BLEEDING;
CHEMICALLY INDUCED DISORDER;
ANTIBODIES, MONOCLONAL;
CORONARY DISEASE;
ELECTROCARDIOGRAPHY;
ENOXAPARIN;
HUMANS;
IMMUNOGLOBULIN FAB FRAGMENTS;
PLATELET AGGREGATION INHIBITORS;
PRACTICE GUIDELINES;
RANDOMIZED CONTROLLED TRIALS;
HEMORRHAGE;
PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;
TICLOPIDINE;
|
EID: 0037070939
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/s0140-6736(02)08300-9 Document Type: Letter |
Times cited : (1)
|
References (0)
|